[1] |
LIU Saiyue, LYU Xiaoqin, ZHOU Yun.
Key points of investigation and report of suspected death of adverse drug reaction
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 971-974.
|
[2] |
YAN Yishu, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Emodin -8-O-β-D-glucoside combined with paclitaxel inhibits the viability and metastasis of human breast cancer cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 728-734.
|
[3] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[4] |
WANG Shuwei, YIN Jinjun, WANG Bing, SONG Caiping, YANG Fujun.
Axitinib tablets combined with toripalimab injection in the treatment of renal cancer-induced central retinal artery occlusion: a case report
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 825-828.
|
[5] |
LI Rongrong, LI Meng, GOU Yue, LUO Qiong, LYU Hua, SUN Xin, LIU Chenghai.
Clinical characteristics and risk factors of 113 cases of anti-neoplastic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 505-510.
|
[6] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[7] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[8] |
ZHENG Jinfeng, WANG Jinghong.
Pharmaceutical care of one case of malignant arrhythmia induced by multidrug combination
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1279-1281.
|
[9] |
ZHOU Pengbo, ZHOU Xiaobing, HUANG Ying, GENG Xingchao.
Research progress in oncolytic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 7-11.
|
[10] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|
[11] |
CHU Yanqi, JIANG Yongxian, SHEN Jianghua, XING Xiaoxuan, ZHANG Qingxia, YAN Suying.
Analgesia-related risks after thoracoscopic surgery in elderly patients
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1023-1026.
|
[12] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[13] |
XIANG Yufang, SUN Hui, CHEN Yue, WANG Ningsheng, LUO Shishu, ZHANG Zhi, FENG Bianling.
Medication safety and combined medication in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 313-316.
|
[14] |
XU Zhe, JU Ping, LUO Qi, YANG Huan, WANG Yang.
930 cases of adverse drug reactions induced by antibacterial drugs in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 317-321.
|
[15] |
ZNANG Lei, WANG Zhifei, XIE Yanming, LI Lixun, LIU Zhishuai.
Complex network analysis of combined medication with Xiyanping injection in treating patients with myocardial damage and myocarditis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 134-136.
|